Center of Expertise on Gender Dysphoria

The Center of Expertise on Gender Dysphoria (CEGD), or the Kennis- en Zorgcentrum Genderdysforie (KZcG), is a transgender clinic at Amsterdam University Medical Centers, location VUmc in Amsterdam, Netherlands.[1][2] It opened in 1975[3] and is one of the largest transgender clinics and research institutes in the world.[1][2] Initially for adults only,[4] from 1987 onwards, a practice dedicated to adolescents opened in Utrecht.[5]:301 The children's clinic merged with the adult clinic in 2002, moving to Amsterdam.[5]:301-302;[Note 1]

As of 2021, it has treated about 10,000 transgender people since it opened almost 50 years previously.[2] The clinic was first headed by Louis Gooren.[6]

Hormone therapy for transgender women was initially done using high-dose estrogen therapy with oral estrogens. Progestogens were also sometimes included.[7] The antiandrogen and progestogen cyproterone acetate was first used in transgender women by 1977.[8][9][10] Its use was standard at the CEGD by 1985.[11][12]

See also

Notes

  1. ^ "The first specialized gender identity clinic for children and adolescents in the Netherlands opened its doors at the Utrecht University Medical Center in 1987. (...) In 2002, the clinic moved to the VU University Medical Center in Amsterdam and is now part of the Center of Expertise on Gender Dysphoria (Cohen-Kettenis & de Vries, 2012, pp. 301-302)."

References

  1. ^ a b Wiepjes CM, Nota NM, de Blok CJ, Klaver M, de Vries AL, Wensing-Kruger SA, de Jongh RT, Bouman MB, Steensma TD, Cohen-Kettenis P, Gooren LJ, Kreukels BP, den Heijer M (April 2018). "The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets". J Sex Med. 15 (4): 582–590. doi:10.1016/j.jsxm.2018.01.016. PMID 29463477.
  2. ^ a b c Een Halve Eeuw Transgenderzorg aan de VU [Half a Century of Transgender Care at the VU] (in Dutch). Amsterdam, Netherlands: Boom Uitgevers Amsterdam. 2020. ISBN 9789024437306. OCLC 1231709484.
  3. ^ https://web-archive-org.translate.goog/web/20231108141504/https://www.bnnvara.nl/zembla/artikelen/tijdlijn-puberteitsremmers?_x_tr_sl=nl&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp
  4. ^ Amsterdam UMC (April 3, 2018). "Terug in de tijd: de geschiedenis van de Genderpoli". www.vumc.nl. Archived from the original on April 15, 2024. Retrieved April 15, 2024.
  5. ^ a b de Vries, Annelou L. C.; Cohen-Kettenis, Peggy T. (March 2012). "Clinical Management of Gender Dysphoria in Children and Adolescents: The Dutch Approach". Journal of Homosexuality. 59 (3): 301–320. doi:10.1080/00918369.2012.653300. ISSN 0091-8369. PMID 22455322.
  6. ^ D. F. Swaab (7 January 2014). We Are Our Brains: A Neurobiography of the Brain, from the Womb to Alzheimer's. Random House Publishing Group. pp. 68–. ISBN 978-0-679-64437-8.
  7. ^ Moore E, Wisniewski A, Dobs A (August 2003). "Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects". The Journal of Clinical Endocrinology and Metabolism. 88 (8): 3467–3473. doi:10.1210/jc.2002-021967. PMID 12915619.
  8. ^ Steinbeck AW (1977). "Of Homosexuality: The Current State of Knowledge". Journal of Christian Education. 20 (2): 58–82. doi:10.1177/002196577702000204. ISSN 0021-9657. S2CID 149168765.
  9. ^ Zingg E, König MP, Cornu F, Wildholz A, Blaser A (1980). "Transsexualismus: Erfahrungen mit der operativen Korrektur bei männlichen Transsexuellen" [Transsexualism: Experience with surgical correction in male transsexuals]. Aktuelle Urologie. 11 (2): 67–77. doi:10.1055/s-2008-1062961. ISSN 0001-7868. S2CID 56512058.
  10. ^ Jequier AM, Bullimore NJ, Bishop MJ (1989). "Cyproterone acetate and a small dose of oestrogen in the pre-operative management of male transsexuals. A report of three cases". Andrologia. 21 (5): 456–461. doi:10.1111/j.1439-0272.1989.tb02447.x. PMID 2530920. S2CID 30370123.
  11. ^ Kuiper AJ, Cohen-Kettenis PT, Van der Reyt F (1985). "Transsexuality in The Netherlands. Some medical and legal aspects". Medicine and Law. 4 (4): 373–378. PMID 3900616.
  12. ^ Prior JC, Vigna YM, Watson D (February 1989). "Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism". Archives of Sexual Behavior. 18 (1): 49–57. doi:10.1007/BF01579291. PMID 2540730. S2CID 22802329.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.